Sumiti Jain

Sumiti Jain is an accomplished scientific leader with extensive experience in immunology and oncology. Currently serving as Chief Scientific Officer at ImmuneBridge since March 2024, Jain previously held the role of VP, Head of R&D at Inceptor Bio and at Stealth Mode Biotech. Jain's expertise includes leading immuno-oncology initiatives as Director at Poseida Therapeutics, Inc. and Associate Director at Sangamo Therapeutics, Inc. Early career highlights include significant contributions at Juno Therapeutics, Inc. and a post-doctoral fellowship at The National Institutes of Health. Jain earned a Ph.D. in Immunology and Virology from McMaster University.